NCT00293709View on ClinicalTrials.gov

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Arthritis, PsoriaticPsoriasisSkin Diseases, Papulosquamous
Interventions
DRUG

etanercept

The patients will be treated in accordance with the requirements of the labelling of Enbrel® in Germany. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment.

Trial Locations (1)

81377

Pfizer Investigational Site, München

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY